Health
Virus drug benefit only marginal: study – Shepparton News

Moderately ill COVID-19 patients had their condition improve after a 5-day course of Gilead Sciences Inc’s remdesivir but the drug did not significantly shorten hospital stays and a 10-day course did not show a benefit, according to new data.The drug, which was shown in a trial of severely ill COVID-19 patients to shorten their hospital recovery time, has been at the forefront of the battle against the pandemic.The 600-patient analysis, published on Friday by the Journal of the American Medical …
-
General10 hours ago
Australian celebrity chef Peter Russell-Clarke dies aged 89
-
Noosa News19 hours ago
Rainbow Beach surfer’s untold 7/7 story
-
Noosa News10 hours ago
Woman airlifted to Brisbane hospital after big cat mauling at south-east Queensland zoo near Toowoomba
-
Noosa News9 hours ago
Unvaccinated horse dies from Hendra virus as Queensland records first case in three years